1
Enquiry period
with 12.12.2025 15:39
to 22.12.2025 16:00
9 days left
2
Bidding period
with 22.12.2025 16:00
to 05.01.2026 13:00
3
Auction

4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 252 000 MDL
Period of clarifications: 12 Dec 2025, 15:39 - 22 Dec 2025, 16:00
Submission of proposals: 22 Dec 2025, 16:00 - 5 Jan 2026, 13:00
Auction start date: will not be used

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Lot 13//Analizator imunologic HIPRO (2)
Information about customer
Fiscal code/IDNO
Address
2062, MOLDOVA, mun.Chişinău, mun.Chişinău, Burebista, 93
Web site
---
The contact person
Full name
Corina Cebuc
Contact phone
022-55-96-46
Purchase data
Date created
12 Dec 2025, 15:36
Date modified
12 Dec 2025, 15:39
Estimated value (without VAT)
252 000 MDL
Achizitii.md ID
21522803
Type of procedure
Open tender
Award criteria
The lowest price
Delivery address
2062, MOLDOVA, mun.Chişinău, mun.Chişinău, Burebista, 93
Contract period
1 Feb 2026 02:00 - 30 Dec 2026 02:00
List of positions
1)
Title
Ig E, teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 400.0
Unit of measurement: Bucata
2)
Title
Ig A,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 200.0
Unit of measurement: Bucata
3)
Title
Ig G,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 200.0
Unit of measurement: Bucata
4)
Title
Ig M,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 200.0
Unit of measurement: Bucata
5)
Title
C-reactiv protein,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 4000.0
Unit of measurement: Bucata
6)
Title
Rheumatoid Factor,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 800.0
Unit of measurement: Bucata
7)
Title
Antistreptolizin -O,teste CPV: 33600000-6 - Pharmaceutical products
Quantity: 1000.0
Unit of measurement: Bucata
Advertising
Documents of the procurement procedure
Question's name
Question
At the moment there are no questions to lot
Clarifications